Though SE was the most effective therapy for Bowen disease, the risk for recurrence with 5-FU and MAL-PDT was negligible.

Yousef and Finger review results of clinical treatment of 101 squamous conjunctival and corneal tumors in 99 patients with at least 6 months (mean, 22 months) of follow-up. The median age of the group ...

The treatment for recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) with immune checkpoint inhibitors (anti-PD1) with or without chemotherapy has led to an improvement in ...

Precision medicine is looking increasingly promising in advanced vulvar squamous cell carcinomas (VSCCs), which make up 90% of vulvar cancers. The emergence of molecular stratification provides ...

A retrospective study reports that the incidence of vulval SCC has remained stable over the past decade, but the diagnosis is delayed due to poor awareness and clinical presentation challenges.